FlexTouch® for the delivery of insulin: technical attributes and perception among patients and healthcare professionals
- PMID: 22471783
- DOI: 10.1586/erd.12.13
FlexTouch® for the delivery of insulin: technical attributes and perception among patients and healthcare professionals
Abstract
Insulin injection pens have improved the ease and convenience of administering insulin for people with diabetes. This article reviews the data on a new prefilled insulin pen, FlexTouch®. FlexTouch has a novel injection mechanism with no push-button extension and a lower injection force than other prefilled pens, and other features including an end-of-dose click; a large dose display; color-coded pens to distinguish different insulin types; an ergonomic design; and compatibility with both NovoTwist® needles and most screw-thread needles. FlexTouch has been demonstrated to deliver insulin consistently and accurately at minimum, half-maximum and maximum doses. In usability studies recruiting patients and healthcare professionals, FlexTouch was easier to use and instilled more confidence than other prefilled pens, and was preferred to other prefilled pens. FlexTouch was also found to be easier to use and was preferred for learning and teaching to use.
Similar articles
-
A prefilled insulin pen with a novel injection mechanism and a lower injection force than other prefilled insulin pens.Diabetes Technol Ther. 2011 Dec;13(12):1207-11. doi: 10.1089/dia.2011.0110. Epub 2011 Aug 24. Diabetes Technol Ther. 2011. PMID: 21864019
-
Healthcare professional and patient assessment of a new prefilled insulin pen versus two widely available prefilled insulin pens for ease of use, teaching and learning.Curr Med Res Opin. 2012 Jan;28(1):3-13. doi: 10.1185/03007995.2011.644427. Epub 2011 Dec 20. Curr Med Res Opin. 2012. PMID: 22114905 Clinical Trial.
-
FlexTouch: a prefilled insulin pen with a novel injection mechanism with consistent high accuracy at low- (1 U), medium- (40 U), and high- (80 U) dose settings.J Diabetes Sci Technol. 2011 Sep 1;5(5):1195-9. doi: 10.1177/193229681100500525. J Diabetes Sci Technol. 2011. PMID: 22027317 Free PMC article.
-
Empowering people with diabetes: improving perceptions and outcomes with technical advances in insulin pens.Postgrad Med. 2012 Sep;124(5):110-20. doi: 10.3810/pgm.2012.09.2587. Postgrad Med. 2012. PMID: 23095431 Review.
-
Dose accuracy and injection force dynamics of a novel disposable insulin pen.Expert Opin Drug Deliv. 2007 Mar;4(2):165-74. doi: 10.1517/17425247.4.2.165. Expert Opin Drug Deliv. 2007. PMID: 17335413 Review.
Cited by
-
User-Centric Approach to Specifying Technical Attributes of Drug Delivery Devices: Empirical Study of Autoinjector-Cap Removal Forces.Patient Prefer Adherence. 2021 Feb 2;15:159-168. doi: 10.2147/PPA.S298725. eCollection 2021. Patient Prefer Adherence. 2021. PMID: 33564226 Free PMC article.
-
Development of an Insulin Pen is a Patient-Centric Multidisciplinary Undertaking: A Commentary.J Diabetes Sci Technol. 2022 May;16(3):617-622. doi: 10.1177/19322968211058707. Epub 2021 Dec 1. J Diabetes Sci Technol. 2022. PMID: 34852662 Free PMC article.
-
NovoPen Echo(®) insulin delivery device.Med Devices (Auckl). 2016 Jan 7;9:11-8. doi: 10.2147/MDER.S59229. eCollection 2016. Med Devices (Auckl). 2016. PMID: 26793007 Free PMC article. Review.
-
Usability of the Novel Liraglutide 3.0 mg Pen Injector Among Overweight or Obese Adult Patients With or Without Prior Injection Experience.J Diabetes Sci Technol. 2015 Jul 16;10(1):164-74. doi: 10.1177/1932296815593295. J Diabetes Sci Technol. 2015. PMID: 26183599 Free PMC article. Clinical Trial.
-
Transjecting growth hormone: continuous nightmare or controlled nuisance? Evaluation of a new needle-free device.Patient Prefer Adherence. 2013 Jul 24;7:703-8. doi: 10.2147/PPA.S46990. Print 2013. Patient Prefer Adherence. 2013. PMID: 23926423 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical